Advanced search
Publication Cover
Epigenomics Volume 5, 2013 - Issue 5
Submit an article Journal homepage
161
Views
0
CrossRef citations to date
0
Altmetric
Review

Genome-Wide Screening for Understanding the Role of DNA Methylation in Colorectal Cancer

Ferenc Sipos1 2nd Department of Internal Medicine, Semmelweis University, Budapest, HungaryCorrespondence[email protected]
,
Györgyi Mũzes1 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary
,
Árpád V Patai1 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary
,
István Fũri1 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary
,
Bálint Péterfia2 1st Department of Pathology & Experimental Oncology, Semmelweis University, Budapest, Hungary
,
Péter Hollósi2 1st Department of Pathology & Experimental Oncology, Semmelweis University, Budapest, Hungary
,
Béla Molnár1 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary;3 Molecular Medicine Research Unit, Hungarian Academy of Sciences, Budapest, Hungary
&
Zsolt Tulassay1 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary;3 Molecular Medicine Research Unit, Hungarian Academy of Sciences, Budapest, Hungary
 show all
Pages 569-581 | Published online: 24 Sep 2013

References

  • Wood LD , ParsonsDW, JonesS et al. The genomic landscapes of human breast and colorectal cancers. Science 318(5853) , 1108–1113 (2007).
  • Laird PW . Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet.11(3) , 191–203 (2010).
  • Laird PW . The power and the promise of DNA methylation markers. Nat. Rev. Cancer3(4) , 253–266 (2003).
  • Schones DE , ZhaoK. Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet.9(3) , 179–191 (2008).
  • Fraga MF , EstellerM. DNA methylation: a profile of methods and applications. Biotechniques33(3) , 632–649 (2002).
  • Pomraning KR , SmithKM, FreitagM. Genome-wide high throughput analysis of DNA methylation in eukaryotes. Methods47(3) , 142–150 (2009).
  • Fouse SD , NagarajanRO, CostelloJF. Genome-scale DNA methylation analysis. Epigenomics2(1) , 105–117 (2010).
  • Huang YW , HuangTH, WangLS. Profiling DNA methylomes from microarray to genome-scale sequencing. Technol. Cancer Res. Treat.9(2) , 139–147 (2010).
  • Estecio MR , YanPS, IbrahimAE et al. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res. 17(10) , 1529–1536 (2007).
  • Weber M , DaviesJJ, WittigD et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37(8) , 853–862 (2005).
  • Taiwo O , WilsonGA, MorrisT et al. Methylome analysis using MeDIP-seq with low DNA concentrations. Nat. Protoc. 7(4) , 617–636 (2012).
  • Jacinto FV , BallestarE, EstellerM. Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. Biotechniques44(1) , 35, 37, 39 passim (2008).
  • Meehan RR , LewisJD, BirdAP. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res.20(19) , 5085–5092 (1992).
  • Down TA , RakyanVK, TurnerDJ et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol. 26(7) , 779–785 (2008).
  • Rauch T , LiH, WuX, PfeiferGP. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res.66(16) , 7939–7947 (2006).
  • Serre D , LeeBH, TingAH. MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res.38(2) , 391–399 (2010).
  • De Meyer T , MampaeyE, VlemmixM et al. Quality evaluation of methyl binding domain based kits for enrichment DNA-methylation sequencing. PLoS One 8(3) , e59068 (2013).
  • Brinkman AB , SimmerF, MaK, KaanA, ZhuJ, StunnenbergHG. Whole-genome DNA methylation profiling using MethylCap-seq. Methods52(3) , 232–236 (2010).
  • Simmer F , BrinkmanAB, AssenovY et al. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics 7(12) , 1355–1367 (2012).
  • Touleimat N , TostJ. Complete pipeline for Infinium® human methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics4(3) , 325–341 (2012).
  • Bibikova M , LinZ, ZhouL et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 16(3) , 383–393 (2006).
  • Jasmine F , RahamanR, RoyS et al. Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed, paraffin-embedded paired tumor and normal tissue. BMC Res. Notes 5 , 117 (2012).
  • Bibikova M , LeJ, BarnesB et al. Genome-wide DNA methylation profiling using Infinium assay. Epigenomics 1(1) , 177–200 (2009).
  • Meissner A , GnirkeA, BellGW, RamsahoyeB, LanderES, JaenischR. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res.33(18) , 5868–5877 (2005).
  • Gu H , SmithZD, BockC, BoyleP, GnirkeA, MeissnerA. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat. Protoc.6(4) , 468–481 (2011).
  • Schillebeeckx M , SchradeA, LöbsAK, PihlajokiM, WilsonDB, MitraRD. Laser capture microdissection-reduced representation bisulfite sequencing (LCM-RRBS) maps changes in DNA methylation associated with gonadectomy-induced adrenocortical neoplasia in the mouse. Nucleic Acids. Res.41(11) , 116 (2013).
  • Boyle P , ClementK, GuH et al. Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling. Genome Biol. 13(10) , R92 (2012).
  • Oda M , GlassJL, ThompsonRF et al. High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res. 37(12) , 3829–3839 (2009).
  • Bock C , TomazouEM, BrinkmanAB et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat. Biotechnol. 28(10) , 1106–1114 (2010).
  • Li N , YeM, LiY et al. Whole genome DNA methylation analysis based on high throughput sequencing technology. Methods 52(3) , 203–212 (2010).
  • Nair SS , CoolenMW, StirzakerC et al. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 6(1) , 34–44 (2011).
  • Clark C , PaltaP, JoyceCJ et al. A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the infinium human methylation450 BeadChip® for methylome profiling. PLoS One 7(11) , e50233 (2012).
  • Pedersen IS , KrarupHB, Thorlacius-UssingO, MadsenPH. High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol. BMC Mol. Biol.13 , 12 (2012).
  • Yokoyama S , KitamotoS, YamadaN et al. The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5´ CpG island of mucin in cancer cells. BMC Cancer 12 , 67 (2012).
  • Tierling S , SchusterM, TetznerR, WalterJ. A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation. Epigenetics Chromatin3(1) , 12 (2010).
  • Kneip C , SchmidtB, FleischhackerM et al. A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling. Biotechniques 47(3) , 737–744 (2009).
  • Bock C , LengauerT. Computational epigenetics. Bioinformatics24(1) , 1–10 (2008).
  • Lister R , PelizzolaM, DowenRH et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271) , 315–322 (2009).
  • Ferlay J , ParkinDM, Steliarova-FoucherE. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer46(4) , 765–781 (2010).
  • Remo A , PancioneM, ZanellaC, VendraminelliR. Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist. Pathologica104(6) , 432–441 (2012).
  • Di L ena M, Travaglio E, Altomare DF. New strategies for colorectal cancer screening. World J. Gastroenterol.19(12) , 1855–1860 (2013).
  • Jones PA , BaylinSB. The epigenomics of cancer. Cell128(4) , 683–692 (2007).
  • Wong NC , CraigJM. Epigenetics: A Reference Manual. Caister Academic Press, Norfolk, England (2011).
  • Cadieux B , ChingTT, VandenBergSR, CostelloJF. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res.66(17) , 8469–8476 (2006).
  • Toyota M , AhujaN, Ohe-ToyotaM, HermanJG, BaylinSB, IssaJP. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA96(15) , 8681–8686 (1999).
  • Fernandez-Rozadilla C , CazierJB, TomlinsonIP et al. A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12. BMC Genomics 14 , 55 (2013).
  • Jiao S , HsuL, BerndtS et al. Genome-wide search for gene–gene interactions in colorectal cancer. PLoS One 7(12) , e52535 (2012).
  • Jia WH , ZhangB, MatsuoK et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet. 45(2) , 191–196 (2013).
  • Wang HM , ChangTH, LinFM et al. A new method for post genome-wide association study (GWAS) analysis of colorectal cancer in Taiwan. Gene 518(1) , 107–113 (2013).
  • Chen W , XiangJ, ChenDF et al. Screening for differentially methylated genes among human colorectal cancer tissues and normal mucosa by microarray chip. Mol. Biol.Rep. 40(5) , 3457–3464 (2013).
  • Kim YH , LeeHC, KimSY et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann. Surg. Oncol. 18(8) , 2338–2347 (2011).
  • Schuebel KE , ChenW, CopeL et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 3(9) , 1709–1723 (2007).
  • Mori Y , CaiK, ChengY et al. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131(3) , 797–808 (2006).
  • Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer . Nature487(7407) , 330–337 (2012).
  • Davis CD , UthusEO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp. Biol. Med. (Maywood)229(10) , 988–995 (2004).
  • Delgado-Plasencia L , Medina-AranaV, Bravo-GutiérrezA et al. Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability. Int. J. Colorectal. Dis. 28(9) , 1187–1193 (2013).
  • Kibriya MG , RazaM, JasmineF et al. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med. Genomics 4 , 50 (2011).
  • van Rijnsoever M , GrieuF, ElsalehH, JosephD, IacopettaB. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut51(6) , 797–802 (2002).
  • Beggs AD , JonesA, El-BahwaryM, AbulafiM, HodgsonSV, TomlinsonIP. Whole-genome methylation analysis of benign and malignant colorectal tumours. J. Pathol.229(5) , 697–704 (2013).
  • Ju HX , AnB, OkamotoY et al. Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis. Am. J. Pathol. 178(4) , 1835–1846 (2011).
  • Yi JM , DhirM, Van Neste L et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin. Cancer Res.17(6) , 1535–1545 (2011).
  • Kim JC , LeeHC, ChoDH et al. Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers. J. Cancer Res. Clin. Oncol. 137(10) , 1571–1580 (2011).
  • Chen B , DodgeME, TangW et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5(2) , 100–107 (2009).
  • Sack U , WaltherW, ScudieroD et al. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Mol. Biol. Cell 22(18) , 3344–3354 (2011).
  • Hinoue T , WeisenbergerDJ, LangeCP et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 22(2) , 271–282 (2012).
  • Weisenberger DJ , SiegmundKD, CampanM et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38(7) , 787–793 (2006).
  • Shen L , ToyotaM, KondoY et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc. Natl Acad. Sci. USA 104(47) , 18654–18659 (2007).
  • Yagi K , AkagiK, HayashiH et al. Three DNA methylation epigenotypes in human colorectal cancer. Clin. Cancer Res. 16(1) , 21–33 (2010).
  • Nosho K , IraharaN, ShimaK et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 3(11) , e3698 (2008).
  • Patai AV , MolnárB, TulassayZ, SiposF. Serrated pathway: alternative route to colorectal cancer. World J. Gastroenterol.19(5) , 607–615 (2013).
  • Ogino S , KawasakiT, KirknerGJ, LodaM, FuchsCS. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J. Mol. Diagn.8(5) , 582–588 (2006).
  • Ogino S , KawasakiT, KirknerGJ, OhnishiM, FuchsCS. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. BMC Cancer7 , 72 (2007).
  • Goel A , NagasakaT, ArnoldCN et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132(1) , 127–138 (2007).
  • Barault L , Charon-BarraC, JoosteV et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res. 68(20) , 8541–8546 (2008).
  • Dahlin AM , PalmqvistR, HenrikssonML et al. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin. Cancer Res. 16(6) , 1845–1855 (2010).
  • Kim JH , ShinSH, KwonHJ, ChoNY, KangGH. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch.455(6) , 485–494 (2009).
  • Zlobec I , BihlM, FoersterA, RufleA, LugliA. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. J. Pathol.225(3) , 336–343 (2011).
  • Yagi K , AkagiK, HayashiH et al. Three DNA methylation epigenotypes in human colorectal cancer. Clin. Cancer Res. 16(1) , 21–33 (2010).
  • Ang PW , LohM, LiemN et al. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 10 , 227 (2010).
  • Yamauchi M , MorikawaT, KuchibaA et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61(6) , 847–854 (2012).
  • Teodoridis JM , HardieC, BrownR. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett.268(2) , 177–186 (2008).
  • Balkwill F , MantovaniA. Inflammation and cancer: back to Virchow? Lancet357(9255) , 539–545 (2001).
  • Olaru AV , ChengY, AgarwalR et al. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Inflamm. Bowel Dis. 18(4) , 641–648 (2012).
  • Patai AV , MolnárB, KalmárA, SchöllerA, TóthK, TulassayZ. Role of DNA methylation in colorectal carcinogenesis. Dig. Dis.30(3) , 310–315 (2012).
  • Tang D , LiuJ, WangDR, YuHF, LiYK, ZhangJQ. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer. Clin. Invest. Med.34(2) , e88–e95 (2011).
  • Lange CP , CampanM, HinoueT et al. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One 7(11) , e50266 (2012).
  • Tóth K , SiposF, KalmárA et al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One 7(9) , e46000 (2012).
  • Bennett KL , KarpenkoM, LinMT et al. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res. 68(12) , 4494–4499 (2008).
  • Grady WM , RajputA, LutterbaughJD, MarkowitzSD. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res.61(3) , 900–902 (2001).
  • Leung WK , ToKF, ManEP et al. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am. J. Gastroenterol. 100(10) , 2274–2279 (2005).
  • Nakayama H , HibiK, TakaseT et al. Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int. J. Camcer 105(4) , 491–493 (2003).
  • Zou HZ , YuBM, WangZW et al. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res. 8(1) , 188–191 (2002).
  • Müller HM , WidschwendterM. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids. Expert Rev. Mol. Diagn.3(4) , 443–458 (2003).
  • deVos T , TetznerR, ModelF et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 55(7) , 1337–1346 (2009).
  • Lofton-Day C , ModelF, DevosT et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem. 54(2) , 414–423 (2008).
  • Wallner M , HerbstA, BehrensA et al. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin. Cancer Res. 12(24) , 7347–7352 (2006).
  • Herbst A , WallnerM, RahmigK et al. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence. Eur. J. Gastroenterol. Hepatol. 21(5) , 565–569 (2009).
  • Tang D , LiuJ, WangDR, YuHF, LiYK, ZhangJQ. Diagnostic and prognostic value of the methylation status of secreted frizzled related protein 2 in colorectal cancer. Clin. Invest. Med.34(2) , e88–e95 (2011).
  • Herbst A , RahmigK, StieberP et al. Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am. J. Gastroenterol. 106(6) , 1110–1118 (2011).
  • Ahlquist DA , TaylorWR, MahoneyDW et al. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin. Gastroenterol. Hepatol. 10(3) , 272–277 (2012).
  • Tänzer M , BalluffB, DistlerJ et al. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 5(2) , e9061 (2010).
  • Li M , ChenWD, PapadopoulosN et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat. Biotechnol. 27(9) , 858–863 (2009).
  • Kim TO , ParkJ, KangMJ et al. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int. J. Mol. Med. 31(5) , 1255–1261 (2013).
  • Balasubramanyam K , VarierRA, AltafM et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279(49) , 51163–51171 (2004).
  • Liu Z , XieZ, JonesW et al. Curcumin is a potent DNA hypomethylation agent. Bioorg. Med. Chem. Lett. 19(3) , 706–709 (2009).
  • Link A , BalaguerF, ShenY et al. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One 8(2) , e57709 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.